In particular, circHOMER1 is significantly downregulated in AD patients and strongly correlates with disease severity as indicated by the clinical dementia rating and Braak score – a measure of AD severity based on distribution and density of neurofibrillary tau tangles in the brain. This evidence concerns the gene MAPT and Alzheimer disease.